Stem Cell Therapy for Knee Arthritis Cost in South-Korea

The cost typically ranges from $4,000 to $9,000 per knee, depending on the stem cell type used. This is often 40-60% less than prices in the US or UK for similar advanced joint treatments.

South Korean specialists primarily use autologous (your own) adipose-derived or bone marrow stem cells, as well as highly regulated umbilical cord blood-derived mesenchymal stem cells.

Yes, South Korea has strict government regulations for regenerative medicine. The Ministry of Food and Drug Safety oversees all stem cell treatments to ensure high safety and quality standards.

Patients usually walk the same day, but full recovery takes 3-6 weeks. Most experience reduced knee pain within 1-2 months as the cartilage regenerates and joint inflammation subsides.

International patients should plan to stay in South Korea for 5 to 7 days. This allows time for initial consultations, the injection procedure, and crucial follow-up post-treatment checkups.

Relief from knee arthritis pain can last 3 to 5 years or more. Results vary based on arthritis severity, patient age, and activity level, with many delaying or avoiding knee replacement.

Ideal candidates are individuals with mild to moderate knee osteoarthritis seeking non-surgical pain relief. It is less effective for severe, bone-on-bone arthritis cases requiring surgery.

The procedure involves minimal discomfort. Doctors administer local anesthesia to numb the knee joint before the stem cell injection, ensuring a nearly painless and quick outpatient experience.

Clinical studies in South Korea show an 80-85% success rate in significantly reducing knee pain and improving joint mobility for patients with early to moderate stages of osteoarthritis.

Treatment packages generally include pre-procedure MRI scans, consultations, the stem cell extraction and injection, and post-procedure physical therapy recommendations or rehabilitation.

Most international health insurance plans do not cover stem cell therapy abroad, classifying it as experimental. Patients should expect to pay out-of-pocket for this regenerative procedure.